相关实验视频
Updated: Jan 6, 2026

07:09
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
49.2K
双重NMR (NOP/MOP) 激动症在疼痛管理中的治疗潜力
Roberto Ciccocioppo1, Jeffrey Gudin2, Charles E Argoff3
1Department of Pharmacology, School of Pharmacy, University of Camerino, Via Madonna Delle Carceri 9, 62032, Camerino, Italy. roberto.ciccocioppo@unicam.it.
Pain and therapy
|December 5, 2025
概括
双核受体/孤儿素FQ (NOP) 和μ-阿片类受体 (MOP) 激动剂显示出有效的疼痛管理的前景. 这些新型化合物可以提供强烈的止痛,同时减少阿片类药物滥用和呼吸系统抑郁等不良影响.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 药物开发 药物开发
背景情况:
- 有效的疼痛管理是一个全球性的挑战,阿片类止痛药存在滥用,依赖和过量死亡的风险.
- 平衡疼痛缓解与安全性是很困难的,因为当前的μ-阿片类受体 (MOP) 激动剂具有显著的不良影响和有限的替代品.
- 诺西塞/孤儿素FQ (NOP) 受体,虽然结构上与阿片类受体相似,但具有独特的药理特征.
研究的目的:
- 探索双重诺西/孤儿素FQ (NOP) 和μ-阿片类受体 (MOP) 激动剂 (NMR激动剂) 作为一种新的治疗策略的潜力.
- 调查NOP和MOP受体的联合激活是否可以提供止痛,同时减轻与阿片类药物相关的不良影响.
主要方法:
- 对非人类灵长类动物的临床前数据和研究进行了审查,研究了NOP受体激活和双NMR激活剂.
- 对各种疼痛模型 (nociceptive,神经病变,炎症) 的止痛疗效的评估.
- 评估NOP受体激活对MOP相关不良结果的影响,包括寻求奖励的行为,耐受性和戒断.
主要成果:
- NOP受体的激活提供疼痛缓解,并对抗MOP相关的不良影响,如高兴感和腹膜区域 (VTA) 的多巴胺活性.
- 临床前数据表明,NOP激活可以减少阿片类药物戒断症状和呼吸系统抑郁.
- 对非人类灵长类动物的研究证实了NOP激素的止痛作用及其减少MOP相关负面结果的能力.
- 双重NMR激活剂显示出潜在的潜力,因为NOP对抗剂增加了MOP类副作用,突出显示了NOP的抵制作用.
结论:
- 双重NMR (NOP/MOP受体) 激动剂代表了治疗疼痛的有希望的新类药物.
- 这些化合物有潜力提供强大的止痛,同时显著降低了阿片类药物滥用和相关不良影响的风险.
相关概念视频
Analgesia and Pain Management
1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
Opioid Receptors: Overview
3.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.8K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
872
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
872
Opioid Analgesics: Morphine and Other Natural Cogeners
796
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
796
Drug-Receptor Interaction: Agonist
3.7K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.7K
Nociception
32.9K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
32.9K

